Results 101 to 110 of about 48,461 (279)

Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress. [PDF]

, 1984
B H Lauterburg, Charles V. Smith, Helen MacGill Hughes, J.R. Mitchell   +3 more
openalex   +1 more source

Self‐Assembled (Aza)BODIPY Dyes for Biomedical in Vivo Imaging

Angewandte Chemie International Edition, EarlyView.
This minireview classifies (aza)BODIPY dyes according to their molecular stacking modes and aggregate types (H‐, oblique‐, or J‐type) in aqueous media, correlating these features with their multimodal imaging performance. By linking molecular design, exciton coupling, and pathway‐dependent assembly, we provide a framework for engineering next ...
Antonia Albers, Max Masthoff, Gustavo Fernández   +2 more
wiley   +1 more source

Nanostructured drug delivery systems for posterior segment eye diseases: Strategies to defy ocular barriers

BMEMat, EarlyView.
Efficient drug delivery to the posterior segment of the eye has long been a challenging issue due to the complex ocular barriers. The review focuses on the promise held by nanoplatforms for barrier penetration and the key mechanisms involved, also highlighting their advantages in achieving efficient drug delivery and superior treatment of PSEDs ...
Yifan Shen, Ying Yao, Yan Zhang, Xinyu Shi, Ling Bai, Yang Zhong, Yan Zhang, Kun Zhang   +7 more
wiley   +1 more source

Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review

Journal of Nanobiotechnology
Spatiotemporally controlled cargo release is a key advantage of nanocarriers in anti-tumor therapy. Various external or internal stimuli-responsive nanomedicines have been reported for their ability to increase drug levels at the diseased site and ...
Xuan Meng, Yongli Shen, Huanyu Zhao, Xinlei Lu, Zheng Wang, Yanjun Zhao   +5 more
doaj   +1 more source

The Synthesis of a Mixed Disulfide of Glutathione and 3-Carboxy-4-nitrobenzenethiol ("Reduced Ellman's Reagent"). [PDF]

, 1970
Bengt Mannervik, Josef Gierer, Björn Lüning, S. Liaaen-Jensen, Aud Lamvik, Erling Sunde, Nils Andreas Sörensen   +6 more
openalex   +1 more source

Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine

BMEMat, EarlyView.
Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo, Nan Li, Daiwei Zhang, Jingya Gu, Zhihuan Liao, Zihao Teng, Xiangfu Du, Peter S. Timashev, Shipeng Chen, Shuaidong Huo   +9 more
wiley   +1 more source

Marine silicon for biomedical sustainability

BMEMat, EarlyView.
Schematic illustrating marine silicon for biomedical engineering. Abstract Despite momentous divergence from oceanic origin, human beings and marine organisms exhibit elemental homology through silicon utilization. Notably, silicon serves as a critical constituent in multiple biomedical processes.
Yahui Han, Zhibo Yang, Wei Xia, Chengtie Wu   +3 more
wiley   +1 more source

GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy

Journal of Nanobiotechnology
The challenges associated with activating ferroptosis for cancer therapy primarily arise from obstacles related to redox and iron homeostasis, which hinder the susceptibility of tumor cells to ferroptosis.
Zhen Liao, E. Wen, Yi Feng
doaj   +1 more source

Influence of Protein-Glutathione Mixed Disulfide on the Chaperone-like Function of α-Crystallin

, 1997
M. Cherian, Jean B. Smith, Xiang‐Yu Jiang, Edathara C. Abraham   +3 more
openalex   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source